Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-08-03

Clinical Trial Update: Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating primidone to improve platelet responsiveness in patients with clopidogrel resistance for secondary stroke prevention was wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMIDONE (Primidone)

Snippet

Sponsor: Dent Neuroscience Research Center | Conditions: Clopidogrel Resistance, Secondary Stroke Prevention | Phase 2 | Status: WITHDRAWN